Our Team


dr nara

Peter Lloyd Nara, MSc, DVM, PhD, FAAAS


Dr. Nara currently is the Chief Executive Officer, President, Chairman & co-founder of Biological Mimetics, Inc. and holds the Endowed Eugene Lloyd Entrepreneurial Chair and Professor in Vaccinology, founding Center Director for the Center for Advanced Host Defense, Immunobiotics, and Translational Comparative Medicine in the Department of Biomedical Sciences, in the College of Veterinary Medicine at Iowa State University, is an adjunct professor of Microbiology/Immunology, Carver College of Medicine, University of Iowa. Dr. Nara holds a M.Sc. in Immuno-pharmacology, a combined Doctor of Veterinary Medicine and Ph.D. (retro-virology/oncogenesis) from The Ohio State University, 4 year combined residency in Comparative Pathology and NIH senior post-doctoral Fellowship at both the Armed Forces Institute of Pathology and the NIH respectively. He has received numerous awards and recognition and in 2011 was elected as a Fellow of the American Association for the Advancement of Science (AAAS) for his work related to Deceptive Imprinting and Immune Refocusing Technology. Dr. Nara and his team while at the NCI were the original discovers of the phenomena of Deceptive Imprinting and invented the first generation of Immune Refocusing Technology.


Garth Ehrlich, PhD, FAAAS

Systemic Microbiology & Genomics

Dr. Garth D. Ehrlich is currently Executive Director of Center for Genomic Sciences at Allegheny-Singer Research Institute. He is Professor of Microbiology and Immunology at the MCP Hahnemann University School of Medicine and the Professor and Vice Chairman, Dept. of Human Genetics at the MCP Hahnemman University School of Medicine.

He is coeditor of PCR-Based Diagnostics in Infectious Disease and author or coauthor of Loss of T cell receptor V-repertoire in HIV-1 infected SCID-hu mice in AIDS Research and Human Retroviruses, Genomic Organization of the Human Fibroblast Growth Factor Receptor 2 (FGFR2) Gene and Comparative Analyses of the Human FGFR Gene Family in Gene, The prevalence of Human T-cell Leukemia Virus Types I and II in various patient populations, retroviral risk groups and healthy blood donors in American Journal of Hematology, RNA differential display of scarless wound healing in fetal rabbit indicates downregulation of a CCT chaperonin subunit and upregulation of a glycophorin-like gene transcript in Journal of Pediatric Surgery, and Pseudomonas aeruginosa Displays Multiple Phenotypes during Development of a Biofilm in Journal of Bacteriology.

He earned his B.A. in Biology with Honors from Alfred University in 1977 and his Ph.D. in Biology from Syracuse University in 1987. He is a consultant for Teltech and is on the Scientific Advisory Board of Radvault and of Bacterin and is doing molecular diagnostic support of clinical trials for Pfizer.

Dr. Dan Sindelar 04-13

Daniel L. Sindelar, DMD

Periodontics & Oral-Systemic Biology

Daniel L. Sindelar DMD attended business school at Saint Louis University and earned a dental degree at Washington University School of Dental Medicine in 1981. He attended the Harvard Executive Management Program in 2015 with a focus on Founders of Successful Startups. He received a Certificate in Finance from Harvard in 2016 with a focus on Valuation.

Over the last 10 years has played the lead role globally in establishing oral pathogens causality of systemic disease including cardiovascular disease.

He is co-founder and past president of the American Academy for Oral Systemic Health (AAOSH). He has earned preceptorship certification by participating with cardiologists in the prevention of heart attack, stroke, and diabetes. He is the founder and director of Oral Genomics, LLC.



Marc Penn, MD, PhD

  • Former Medical Director, Cardiac ICU, Cleveland Clinic
  • Former Director, Bakken Heart-Brain Institute
  • Chief Medical Officer, Cleveland Heartlab
  • Professor of Integrative Medical Sciences, Northeast Ohio Medical University

StJohn Crean, PhD

  • Executive Dean of College of Clinical and Biomedical Sciences, University of Central Lancashire
  • Robert Bradlaw advisor, Faculty of Dental Surgery at the Royal College of Surgeons of England
  • Editor-in-Chief, Faculty Dental Journal

W. Sue T. Griffin, PhD

  • Editor-in-Chief, Journal of Neuroinflammation
  • Dillard Professor & Vice Chairman, Donald W. Reynolds Dept. of Geriatrics, University of Arkansas for Medical Sciences
  • Director of Research, Geriatric Research, Education and Clinical Center, VAMC/CAVHS

Angela Kamer, DDS

  • Research Scientist, NYU School of Medicine Center for Brain Health
  • Associate Professor of Periodontology & Implant Dentistry, New York University

Sim K. Singhrao, PhD

  • Senior Research Fellow, University of Central Lancashire School of Medicine & Dentistry